Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 636,554 |
|
|||||
| News | - | ||||||
| Day High | 24.64 | Low High |
|||||
| Day Low | 23.47 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Xencor Inc | XNCR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.13 | -0.54% | 23.76 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 24.03 | 23.47 | 24.64 | 23.76 | 23.89 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,488 | 636,554 | US$ 23.88 | US$ 15,198,941 | - | 16.49 - 28.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:00 | 16 | US$ 23.76 | USD |
Xencor Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.45B | 61.12M | - | 168.34M | -126.09M | -2.06 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Xencor News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XNCR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 23.89 | 24.64 | 22.49 | 23.50 | 457,444 | -0.13 | -0.54% |
| 1 Month | 24.26 | 25.09 | 20.31 | 23.15 | 588,535 | -0.50 | -2.06% |
| 3 Months | 23.90 | 25.09 | 17.945 | 22.12 | 636,418 | -0.14 | -0.59% |
| 6 Months | 18.50 | 26.84 | 17.82 | 21.69 | 680,696 | 5.26 | 28.43% |
| 1 Year | 27.13 | 28.00 | 16.49 | 21.69 | 512,366 | -3.37 | -12.42% |
| 3 Years | 38.50 | 43.61 | 16.49 | 26.40 | 378,631 | -14.74 | -38.29% |
| 5 Years | 31.25 | 58.345 | 16.49 | 30.57 | 368,318 | -7.49 | -23.97% |
Xencor Description
| Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates. |
